Business - Briefly   

Pain management tablet from Dr. Reddy’s

HYDERABAD: Dr. Reddy’s Laboratories (DRL) has launched Supanac (Diclofenac potassium immediate release 50 mg tablets) in India. Supanac is in-licensed from Applied Pharma Research (APR), Switzerland, and is used for acute pain management, according to a company release. — Special Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

EAC favours tax sops to spur growth
TCS revenue crosses $4 b in April-Dec.
Iran ready to open $22 b LNG deal
Hindustan Sanitaryware enters organised retailing
Infosys BPO to clinch four deals
‘Pollution begins when conservation fails’
KURDFC registers Rs. 1.87 crore profit in 2006-07
Spices exporters eyeing Japanese markets
CMRL enters into technology transfer pact with NIIST
Tata Steel ties up with Oman firm
EU raids pharma companies in broad inquiry
Oracle agrees to buy BEA Systems for $7.85 billion
Vedanta plans steel foray
India Cements profit up
Patel for lowering of taxes on ATF
Sensex plunges on U.S. recession worries
Exchange Rates
Bullion Rates
Apollo Tyres to set up unit in Hungary
Fine on telcos for telemarketing calls
DSE to revive trading platform
Bank’s forecast on rupee-dollar rate
Single bank account for exporters
PE firms approach GoAir to pick up stake
SabseBolo.com launched
Pain management tablet from Dr. Reddy’s
JSW Steel buys mining concessions in Chile
NIIT acquires equity stake in Evolv
J. Kumar Infraprojects to tap market
Zen Tech’s turnaround performance in Q3
Cathay Pacific to begin services to Chennai
New Associate Vice-President for Servion

Copyright © 2008, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu